The U.S. Agency for International Development (USAID) has committed $2.3 million to purchase 4.8 million doses of malaria medication from Swiss Pharma (Swipha).
Trending
- NITDA partners Flutterwave, Alami to promote digital transformation
- [EXPLAINER] What are the truth about dietary fat?
- Spinal cord association unveils policy to support PwDs
- NiMet predicts sunshine, haziness from Saturday
- FG plans revitalization of veterinary institute to meet vaccine needs
- Nigeria plans establishment of gene bank to preserve local livestock breeds
- Coconut traders task farmers on high-quality seedlings
- Bring empirical evidence, scientist challenges GMO critics
